Zhang, X.; Zhang, N.; Chrenek, M.A.; Girardot, P.E.; Wang, J.; Sellers, J.T.; Geisert, E.E.; Brenner, C.; Nickerson, J.M.; Boatright, J.H.;
et al. Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage. Pharmaceutics 2021, 13, 893.
https://doi.org/10.3390/pharmaceutics13060893
AMA Style
Zhang X, Zhang N, Chrenek MA, Girardot PE, Wang J, Sellers JT, Geisert EE, Brenner C, Nickerson JM, Boatright JH,
et al. Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage. Pharmaceutics. 2021; 13(6):893.
https://doi.org/10.3390/pharmaceutics13060893
Chicago/Turabian Style
Zhang, Xian, Nan Zhang, Micah A. Chrenek, Preston E. Girardot, Jiaxing Wang, Jana T. Sellers, Eldon E. Geisert, Charles Brenner, John M. Nickerson, Jeffrey H. Boatright,
and et al. 2021. "Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage" Pharmaceutics 13, no. 6: 893.
https://doi.org/10.3390/pharmaceutics13060893
APA Style
Zhang, X., Zhang, N., Chrenek, M. A., Girardot, P. E., Wang, J., Sellers, J. T., Geisert, E. E., Brenner, C., Nickerson, J. M., Boatright, J. H., & Li, Y.
(2021). Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage. Pharmaceutics, 13(6), 893.
https://doi.org/10.3390/pharmaceutics13060893
